Senti Biosciences (SNTI) Short Interest Ratio & Short Volume → Nvidia’s Quiet $1 Trillion Pivot (From Weiss Ratings) (Ad) Free SNTI Stock Alerts $0.32 -0.02 (-5.83%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Senti Biosciences Short Interest DataCurrent Short Interest281,400 sharesPrevious Short Interest287,300 sharesChange Vs. Previous Month-2.05%Dollar Volume Sold Short$106,366.39Short Interest Ratio2.6 Days to CoverLast Record DateMay 15, 2024Outstanding Shares45,760,000 sharesFloat Size27,580,000 sharesShort Percent of Float1.02%Today's Trading Volume88,590 sharesAverage Trading Volume120,306 sharesToday's Volume Vs. Average74% Short Selling Senti Biosciences ? Sign up to receive the latest short interest report for Senti Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSNTI Short Interest Over TimeSNTI Days to Cover Over TimeSNTI Percentage of Float Shorted Over Time Ad Weiss RatingsNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. Senti Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024281,400 shares $106,366.39 -2.1%1.0%2.6 $0.38 4/30/2024287,300 shares $103,428.00 +73.9%1.1%2.5 $0.36 4/15/2024165,200 shares $49,758.24 -22.7%0.6%2 $0.30 3/31/2024213,800 shares $80,623.98 -4.2%0.8%2.1 $0.38 3/15/2024223,200 shares $83,253.60 -17.3%0.8%0.3 $0.37 2/29/2024269,900 shares $116,057.00 -21.9%1.0%0.4 $0.43 Get the Latest News and Ratings for SNTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Senti Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024345,400 shares $146,795.00 +15.1%1.3%0.5 $0.43 1/31/2024300,000 shares $135,030.00 -30.4%1.2%0.1 $0.45 1/15/2024430,700 shares $232,147.30 -44.1%1.6%0.2 $0.54 12/31/2023769,900 shares $508,134.00 +60.8%2.9%0.3 $0.66 12/15/2023478,900 shares $182,987.69 -42.6%1.8%0.2 $0.38 11/30/2023834,000 shares $358,703.40 -44.4%3.2%0.3 $0.43 11/15/20231,500,000 shares $557,700.00 +260.1%5.7%0.6 $0.37 10/31/2023416,500 shares $116,536.70 -8.2%1.6%0.2 $0.28 10/15/2023453,800 shares $137,002.22 +100.6%1.7%1.6 $0.30 9/30/2023226,200 shares $93,420.60 +7.2%0.9%0.9 $0.41 9/15/2023211,000 shares $122,823.10 -32.7%0.8%2.9 $0.58 8/31/2023313,400 shares $203,710.00 -6.8%1.5%4.6 $0.65 8/15/2023336,300 shares $242,472.30 -10.1%1.6%4.8 $0.72 7/31/2023374,200 shares $322,560.40 -12.3%1.9%5.3 $0.86 7/15/2023426,500 shares $298,550.00 +24.9%2.1%4.4 $0.70 6/30/2023341,400 shares $214,057.80 -15.1%1.4%3.5 $0.63 6/15/2023402,300 shares $402,300.00 -12.8%1.6%4.6 $1.00 5/31/2023461,100 shares $407,566.29 -11.0%1.8%5.3 $0.88 5/15/2023517,900 shares $502,363.00 +2.9%2.0%5.8 $0.97 4/30/2023503,500 shares $493,430.00 -0.5%1.9%5.4 $0.98 4/15/2023506,100 shares $541,527.00 +0.2%2.0%4.9 $1.07 3/31/2023505,200 shares $596,136.00 -9.0%2.0%5.3 $1.18 3/15/2023555,200 shares $705,104.00 +12.6%2.2%5.4 $1.27 2/28/2023493,100 shares $739,650.00 -4.4%1.9%2.7 $1.50 2/15/2023515,500 shares $860,885.00 -13.1%2.0%2.8 $1.67 1/31/2023593,300 shares $1.09 million -5.1%1.7%2.8 $1.83 1/15/2023625,100 shares $1.18 million +1.6%1.8%2.4 $1.89 12/30/2022615,500 shares $867,855.00 +65.6%1.8%0.9 $1.41 12/15/2022371,800 shares $565,136.00 -12.3%1.1%0.1 $1.52 11/30/2022423,900 shares $974,970.00 -6.8%1.2%0.1 $2.30 11/15/2022454,700 shares $1.10 million -12.0%1.3%0.1 $2.43 10/31/2022516,900 shares $1.20 million -20.1%1.5%0.1 $2.32 10/15/2022646,600 shares $2.11 million -1.8%1.9%0.1 $3.27 9/30/2022658,400 shares $1.43 million +265.6%1.9%0.1 $2.17Nvidia’s Quiet $1 Trillion Pivot (Ad)Nvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. 9/15/2022180,100 shares $405,225.00 -23.0%0.5%0.1 $2.25 8/31/2022234,000 shares $458,640.00 -16.1%0.7%0.2 $1.96 8/15/2022278,800 shares $568,752.00 -3.5%0.8%0.2 $2.04 7/31/2022288,900 shares $904,257.00 +110.1%0.9%0.2 $3.13 7/15/2022137,500 shares $247,500.00 No Change0.4%0.4 $1.80 SNTI Short Interest - Frequently Asked Questions What is Senti Biosciences' current short interest? Short interest is the volume of Senti Biosciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 281,400 shares of SNTI short. 1.02% of Senti Biosciences' shares are currently sold short. Learn More on Senti Biosciences' current short interest. What is a good short interest ratio for Senti Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNTI shares currently have a short interest ratio of 3.0. Learn More on Senti Biosciences's short interest ratio. What is a good short interest percentage for Senti Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.02% of Senti Biosciences' floating shares are currently sold short. Is Senti Biosciences' short interest increasing or decreasing? Senti Biosciences saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 281,400 shares, a decline of 2.1% from the previous total of 287,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Senti Biosciences' float size? Senti Biosciences currently has issued a total of 45,760,000 shares. Some of Senti Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Senti Biosciences currently has a public float of 27,580,000 shares. How does Senti Biosciences' short interest compare to its competitors? 1.02% of Senti Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Senti Biosciences: PharmaCyte Biotech, Inc. (0.17%), Aptose Biosciences Inc. (0.70%), Evaxion Biotech A/S (0.89%), Coeptis Therapeutics Holdings, Inc. (0.28%), BioCardia, Inc. (0.86%), Genetic Technologies Limited (0.48%), Organovo Holdings, Inc. (3.41%), Scinai Immunotherapeutics Ltd. (0.32%), Creative Medical Technology Holdings, Inc. (1.34%), Titan Pharmaceuticals, Inc. (1.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Senti Biosciences stock? Short selling SNTI is an investing strategy that aims to generate trading profit from Senti Biosciences as its price is falling. SNTI shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Senti Biosciences? A short squeeze for Senti Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SNTI, which in turn drives the price of the stock up even further. How often is Senti Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNTI, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PharmaCyte Biotech Short Interest Aptose Biosciences Short Interest Evaxion Biotech A/S Short Interest Coeptis Therapeutics Short Interest BioCardia Short Interest Genetic Technologies Short Interest Organovo Short Interest Scinai Immunotherapeutics Short Interest Creative Medical Technology Short Interest Titan Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNTI) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for AIWeiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock Digest Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.